Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Gains from Investment Securities (2016 - 2025)

Lineage Cell Therapeutics' Gains from Investment Securities history spans 16 years, with the latest figure at -$1.3 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 4180.65% year-over-year to -$1.3 million; the TTM value through Dec 2025 reached $9.2 million, up 32760.71%, while the annual FY2025 figure was $860000.0, 91.46% down from the prior year.
  • Gains from Investment Securities reached -$1.3 million in Q4 2025 per LCTX's latest filing, down from $35.3 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $35.3 million in Q3 2025 to a low of -$2.3 million in Q1 2025.
  • Average Gains from Investment Securities over 5 years is $8.3 million, with a median of $5.8 million recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 42072.41% in 2022, then crashed 4180.65% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at -$29000.0 in 2021, then surged by 42072.41% to $12.2 million in 2022, then crashed by 99.89% to $13000.0 in 2023, then soared by 138.46% to $31000.0 in 2024, then plummeted by 4180.65% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for LCTX's Gains from Investment Securities are -$1.3 million (Q4 2025), $35.3 million (Q3 2025), and $12.7 million (Q2 2025).